Literature DB >> 14654761

Additive effects of hypertension and diabetes on renal cortical expression of PKC-alpha and -epsilon and alpha-tubulin but not PKC-beta 1 and -beta 2.

Tanya M Osicka1, Leileata M Russo, Mei-Lan Qiu, Gail C Brammar, Vicki Thallas, Josephine M Forbes, Wayne D Comper, George Jerums.   

Abstract

OBJECTIVE: This study examined the separate and combined effects of hypertension and diabetes on renal cortical expression of protein kinase C (PKC) isoforms -beta 1, -beta 2, -alpha and -epsilon, to determine whether albuminuria is the result of an increase in the expression of one or a combination of PKC isoforms. Corresponding changes in renal microtubules were also assessed.
METHODS: Diabetes (D) was induced in Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) by streptozotocin. After 24 weeks, PKC expression was determined by Western blot and microtubules were assessed by immunohistochemistry for alpha-tubulin protein.
RESULTS: Diabetes was characterized by significant increases in glycated haemoglobin (HbA1c) as compared to controls (C). There was a significant increase of three- to four-fold in PKC protein content for all four isoforms in renal cortex from SHR-C and WKY-D, and similar and significant levels of albuminuria (approximately 10 mg/24 h) observed in these groups in comparison to WKY-C (approximately 1 mg/24 h). Interestingly, PKC-alpha and -epsilon but not PKC-beta 1 and -beta 2 protein content was doubled in SHR-D, and albuminuria increased tenfold (approximately 100 mg/24 h) in comparison to SHR-C and WKY-D. These changes were paralleled by a significant decrease in alpha-tubulin protein content of approximately 50% in SHR-C and approximately 33% in WKY-D compared to WKY-C, with a further decrease of approximately 67% in SHR-D compared to WKY-C.
CONCLUSION: These findings indicate that PKC expression can be increased by either diabetes or hypertension, and that there are further specific increases in the expression of PKC isoforms -alpha and -epsilon in the model of combined diabetes and hypertension. In addition, the degree of disruption in microtubular cytoskeleton appears to be correlated with PKC activation and levels of albuminuria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654761     DOI: 10.1097/00004872-200312000-00029

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  3 in total

1.  O-GlcNAcylation and phosphorylation of β-actin Ser199 in diabetic nephropathy.

Authors:  Yoshihiro Akimoto; Kunimasa Yan; Yuri Miura; Hiroki Tsumoto; Tosifusa Toda; Toshiyuki Fukutomi; Daisuke Sugahara; Akihiko Kudo; Tomio Arai; Yuko Chiba; Shinya Kaname; Gerald W Hart; Tamao Endo; Hayato Kawakami
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

2.  Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction.

Authors:  Reyna L VanGilder; Jason D Huber
Journal:  Postdoc J       Date:  2014-07

Review 3.  Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression.

Authors:  Anna Csiszar; Stephanie Lehoux; Zoltan Ungvari
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.